Cargando…
Next‐generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity
The promise of ‘personalized cancer care’ with therapies toward specific molecular aberrations has potential to improve outcomes. However, there is recognized heterogeneity within any given tumor‐type from patient to patient (inter‐patient heterogeneity), and within an individual (intra‐patient hete...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402102/ https://www.ncbi.nlm.nih.gov/pubmed/25557400 http://dx.doi.org/10.1016/j.molonc.2014.09.011 |